Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

A medicine used to treat and help prevent the flu may put patients at risk for a rare but life-threatening condition in which the skin peels off the body in sheets, according to the Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research. The agency notified the public that it has approved safety label changes for Relenza (zanamivir) Inhalation Powder for oral inhalation. The Adverse Reactions section of the drug’s new safety label now includes a risk of rash, including serious cutaneous reactions (e.g. erythema multiforme, Stevens Johnson Syndrome, SJS, and toxic epidermal necrolysis, TEN).

Read the rest of this entry »

A medication used for the management of hypertension now includes an updated safety label that warns patients of a rare but serious skin condition, according to the Food and Drug Administration (FDA)’s Safety Information and Adverse Event Reporting Program. The new safety label for Inderide (propranolol HCL/hydrochlorothiazide) tablets carries a warning of “erythema multiforme including Stevens Johnson Syndrome (SJS), exfoliative dermatitis, including toxic epidermal necrolysis (TEN)” in the Adverse Reactions section.

Read the rest of this entry »

Drug maker Tibotec, which specializes in innovative therapeutic and diagnostic solutions for infectious diseases such as HIV/AIDS, is seeking approval from the FDA for its latest HIV treatment, Intelence, based on data from its phase-three studies of the drug when used in combination with other antiretroviral agents, according to a press release from Hays Pharma, a global pharmaceutical and biotech staffing and recruitment business.

Read the rest of this entry »

A prescription drug given to counter a side effect of radiation for head and neck cancer now carries a warning about possible serious adverse reactions to the medication known as Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN). Ethyol (amifostine) was among 29 drugs listed in a Jan. 30th FDA MedWatch announcement of drug products with safety labeling changes to their boxed warnings, contraindications, warnings, precautions, adverse reactions, patient package inserts and medication guides.

Read the rest of this entry »

PEGASYS, a new medication proven effective in the treatment of hepatitis C for Latino patients caused a severe adverse skin reaction known as erythema multiforme major, or Stevens Johnson Syndrome (SJS), in patients during post-approval use, according to Cloud Computing Journal. The article referenced a study published in the New England Journal of Medicine.

Read the rest of this entry »

Last week, after weeks of alarming medical symptoms, Backstreet Boys band member Brian Littrell finally has a diagnosis for his ailing 6-year-old son Baylee – Kawasaki Disease, according to the singer’s Web page. Kawasaki Disease, or KD, is a serious illness that involves the skin, mouth and lymph nodes. If symptoms are recognized early, a full recovery can be expected. If left untreated, it can cause serious heart complications.

Read the rest of this entry »

Adverse reactions to antibiotics send more than 140,000 Americans to the emergency room every year, according to a study by the U.S. Centers for Disease Control and reported this month by Natural News.

Researchers centered their focus on antibiotics that were either ingested or injected rather than those that are applied to the skin. Data was pulled from the National Ambulatory Medical Care Survey, National Hospital Ambulatory Medical Care Survey, National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project. The data showed that 19 percent of all emergency visits for adverse reactions to drugs were due to antibiotics.

Read the rest of this entry »